Nandrolone Steroid
Hot Products
  • Methenolone Enanthate
    Primobolan

    Primobolan is one of the few steroids that can regularly be found in both oral and injectable forms; Methenolone-Enanthatebeing the injectable and Methenolone-Acetate the oral. A once fairly popular anabolic steroid, Primobolan is not nearly as popular as it once was; however, due to rumors surrounding Arnold Schwarzenegger implying it was his favorite, to this day there remains a strong almost cult like following. While there is no question, Primobolan is one of the safer steroids we can use in-terms of side-effects because Masteron is more readily available and far less counterfeited many in recent years have opted for that rout. However, as these two steroids are often compared in truth and function they carry very specific differing traits; more importantly, the counterfeiting factor cannot be ignored. Yes, unfortunately Primobolan is one of the more commonly counterfeited steroids on the black market, especially the tablets but in high amounts in both forms. Nevertheless, legitimate Primo as it is commonly called, while a very mild steroid can be well suited for cutting cycles but generally for most there is little benefit otherwise. However, for the female anabolic steroid user, as Primobolan is very mild in nature it can often be a fine choice as side-effects are very easy to control and often non-existent when used responsibly.

  • hgh steroids   synthetic human growth hormone
    Original Strongtropin hgh with anti-fake code

    STRONGTROPIN HGH with anti-fake code  is the genuine HGH with the best quality, 10 IU/vial. But there are some fake STRONGTROPIN HGHs in the market now. This brand is is our company's right. Any use not from our company is illegal. Our company will often change the top's color against the fake one. If top's color of STRONGTROPIN you bought is not the same as picture shows, it is fake.

  • Hgh steroids   synthetic human growth hormone
    12 IU HGH Injectable Human Growth Hormone Steroids Nordictropin

    Sometimes people’s bodies don’t produce enough growth hormone on their own. This is called growth hormone deficiency. When this happens, both children and adults may be treated with man-made growth hormone called recombinant human growth hormone. This hormone is identical to the growth hormone that human bodies make.

  • kigtropin
    kigtropin hgh

    HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet. The Three Groups Of People Who Need Human Growth Hormone Human growth hormones are produced by the pituitary gland and are more prevalent when we are young. However, some people do not produce enough naturally, or they may need supplements for other reasons.

  • Hgh steroids   synthetic human growth hormone
    Natural Riptropin Human Growth Hormone Steroids 10 IU Real HGH Injections

    Riptropin [rDNA origin] is a way to supply natural growth human growth hormone for people who may deficient or may require higher levels of this hormone. Riptropin is identical to natural growth hormone that your pituitary gland produces because it is made by secretion technology that makes a 191 amino acid sequence.

  • Melanotan II
    Injecting Anabolic Steroids MT 2 Melanotan II

    The initial creation of the synthetic Melanotan 2 peptide can be credited to the University of Arizona. During the course of research aimed at developing a defense against skin cancer, focus was placed on developing a method of stimulating natural melanogenesis, or the natural production of melanin in the skin, without direct exposure to the potentially harmful ultraviolet radiation in sunlight.

About Us

HongKong Health-keeping Bio-technology Company Ltd is located in Hongkong, focusing on production and distribution of biologicals, peptides, hormone, medicines and health products in China, and technological service in pharmaceutical industry. All the managers and engineers are experts in the fields of biochemistry, chemistry, or pharmaceuticals.


They have been producing these kinds of products or technological service for at least 10 years. KDSMED is always paying much attention to quality assurance and quality control. Its products and technology are widely and safely used in many countries, and have good effect.


HongKong Health-keeping Bio-technology Company Ltd is now cooperating with many distributors, pharmaceutical factories, institutes and laboratories.

You are welcome to visit our website and to contact us. We will reply all of your emails within 24 hours


The company's factory is Occupying 10,000 sequre meters. Total buildings have 8,000 sequre meters, 4000 for production, 2000 for QC and QA, 1000 for administration, and 1000 for others. We have 6 departments as following picture show.

1. Company Management



There are production department, R&D department, QC department, QC department, accounting department, marketing department and administration department. And the company has one general manager, one technology supervisor and one vice-general manager.

Our company has built up a complete modern genetic engineering drugs production workshop and facilities, while equipped with advanced production technology and devices.


It has also set up a professional R&D department and gradually increased the R&D funding in the past three years for constant scientific and technological personnel introduction, scientific instruments and equipment procurement and further facilities improvement. Since the company was eastashed, we paid more attention to the new technologies research and development. Based on the existing technology platform, we have made breakthrough at the development of new indications, new applications, new specifications and new dosage forms, and formed a versatile products line including the products on sale and under R&D. While developing the new project, we applied for related patents and formed our own independent intellectual property rights.


2. The main products


Now we can supply HGH(human growth hormone) for injection, 10 IU and its raw material powder. The production capability is at least 500,000 vials of IUs each month, or 2000 grams of raw material HGH lyophilized powder. The purity is more than 96%,  10 IU = 3.7mg.


We can also supply HCG, EPO, peptides, steroid products, etc. Please check the product list.


2.1. Real 10 IU HGH Prices for 2017


Different minimum order quantity has different prices.

Real 10 IU HGH Prices for 2017
Specification Minimum Order Quantity
unlabelled 10 IU/vial (lyophilized powder) purity ≥ 95% (different lips or colors available) 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
STRONGTROPIN 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
Nipertropin 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
Nordictropin 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
Jintropin 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
Riptropin 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
Kigtropin 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
Hygetropin 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
Genetropin 10 IU/vial (lyophilized powder) purity ≥ 95% 10 vials
100 vials
1,000 vials
10,000 vials
100,000 vials
HGH powder (lyophilized powder) (0.37mg/IU ) Purity ≥95% 10 grams
50 grams
100 grams
1000 grams




2.2. Peptide Lists


Peptide name Unit per vial
Follistatin 344 lyophilized powder purity ≥95% 1mg
IGF-1 LR3 1mg
IGF-1 LR3 0.1
IGF-1 LR3 lyophilized powder purity ≥95% 1 mg
MGF 2mg
PEG MGF 2mg
CJC-1295 DAC 2mg
CJC-1295 2mg
PT-141 10mg
MT-1 10mg
MT-2 10mg
GHRP-2 5mg
GHRP-6 5mg
Ipamorelin 2mg
Hexarelin 2mg
Sermorelin 2mg
Oxytocin 2mg
TB500 2mg
HGH 176-191 2mg
Triptorelin 2mg
Tesamorelin 2mg
Gonadorelin 2mg
DSIP 2mg
Selank 5mg



2.3. Steroid Products List


Name CAS
Diosgenin CAS# 512-04-9
16-Dehydro Pregnenolone Acetate(16-DPA) CAS# 979-02-2
16,17a-Epoxyprogesterone CAS# 1097-51-4
Boldenone Undecylenate CAS# 13103-34-9
Boldenone CAS# 846-48-0
DHEA (Dehydroepiandrosterone)& derivatives CAS# 53-43-0
Estradiol CAS# 50-28-2
Ethinyl Estradiol CAS# 57-63-6
Estriol CAS# 50-27-1
Conjugated Estrogen CAS# 12126-59-9
Estrone CAS# 53-16-7
Formestane CAS# 566-48-3
Gestodene CAS# 60282-87-3
17a-hydroxyprogesterone acetate CAS# 302-23-8
17a-hydroxyprogesterone CAS# 68-96-2
Medroxyprogesterone acetate CAS# 71-58-9
Megestrol acetate CAS# 595-33-5
Mestanolone CAS# 521-11-9
Mesterolone CAS# 1424-00-6
Methandienone (methandrostenolone) CAS# 72-63-9
Methenolone CAS# 153-00-4
Methenolone acetate CAS# 434-05-9
Methenolone enanthate CAS# 303-42-4
Mifepristone CAS# 84371-65-3
6a-methylprednisolone & acetate CAS# 83-43-2 & 53-36-1
Estra-4,9-diene-3, 17-dione CAS# 5173-46-6
Levonorgestrel CAS# 797-63-7
Trenbolone & derivatives CAS# 10161-33-8
Norethisterone & acetate CAS# 68-22-4 &51-98-9
Oxymetholone CAS# 434-07-1
Oxandrolone CAS# 53-39-4
Progesterone CAS# 57-83-0
Pregnenolone CAS# 145-13-1
Stanolone CAS# 521-18-6
Stanozolol CAS# 10418-03-8
Tibolone CAS# 5630-53-5
Allylestrenol CAS# 432-60-0
Prasterone Enanthate CAS# 23983-43-9
Estradiol Cypionate CAS# 313-06-4
Ethisterone CAS# 434-03-7
Drostanolone Propionate CAS# 521-12-0
Exemestane CAS# 107868-30-4
Testosterone CAS# 58-22-0
Testosterone Cypionate CAS# 58-20-8
Testosterone Decanoate CAS# 5721-91-5
Testosterone Enanthate CAS# 315-37-7
Fluoxymesterone CAS# 76-43-7
4-Hydroxy Testosterone
4-Hydroxy Testosterone Acetate
Testosterone Isocaproate CAS# 15262-86-9
Testosterone Phyenylpropionate CAS# 1255-49-8
Testosterone Propionate CAS# 57-85-2
Testosterone Undecanoate CAS# 5949-44-0
Testosterone Isobutyrate CAS# 1169-49-9
Clostebol acetate (Chlordehydromethyl testosterone acetate) CAS# 855-19-6
Epitestosterone CAS# 481-30-1
Methyltestosterone CAS# 58-18-4
Nandrolone & derivatives CAS# 434-22-0
Nandrolone Decanoate CAS# 360-70-3
Nandrolone Phenypropionate CAS# 62-90-8
Normethisterone CAS# 514-61-4
Nandrolone Cypionate CAS# 601-63-8
Trenbolone CAS# 10161-33-8
Trenbolone Acetate /Enanthate CAS# 10161-34-9
Metribolone (Methyltrienolone) CAS# 965-93-5
17a-methyl-1-Testosterone CAS# 58-18-14


2.4. Steroid finished products


Testosterone undecanoate injection 2ml x 250 mg/vial (liquid)/box
Testosterone undecanoate soft capsule 40mg/capsule, 16 capsules/box
Testosterone propionate 25mg x 1ml/vial
menotropin for injection 75 iu/vial, 5 vials/box
HCG injection 5000 IU/vial with water
methyltestosterone tablet 5mg/tablet, 100tablets/bottle
Tamoxifen Citrate 10mg*60tablets/box
clomid (clomiphene citrate tablet) 50mg/tablet, 20 tablets/box
Arimidex (Anastrozole) 1mg x 14 tablets/box



2.5. EPO products list


Different minimum order quantity have different prices.

Specification Minimum Order Quantity
5000 IU/Vial liquid in vial 100 pcs
100 pcs
1,000 pcs
4000 IU/Vial liquid in vial 100 pcs
1,000 pcs
10,000 pcs
100,000 pcs
3000 IU/Vial liquid in vial 100 pcs
1,000 pcs
10,000 pcs
100,000 pcs
3000 IU/pfs liquid in prefilled syringe 50 pcs
100 pcs
1,000 pcs
3000 IU/vial (lyophilized powder in vial) 100 pcs
1,000 pcs
10,000 pcs
10000 IU/Vial liquid in vial
Company Information
Basic Information
Company Name: Hongkong Health-keeping bio-technology Co., Limited
Business Type: Manufacturer,Distributor/Wholesaler,Importer,Exporter
Brands: STRONGTROPIN
Employee Number: 100~200
Year Established: 2010
Total Sales Annual: 10,0000,000-20,000,000

Factory Location: 28# Jichang Avenue, Baiyun District, Guangzhou, China



To make pure water


Tap water is fistly filtered by sand filter culum, then treated by cation exchange colum, and filtered by reverse osmosis membrane, then treated by anion exchange colum and cation exchange colum.


To make water for injection


Pure water is treated by distillation machine to make water for injection.



2. the process of making HGH vials is following.


For example, 50,000 vials of HGH.


1. prepare 55,000 ml of sterile water for injection, and 2500 grams of mannitol pharmacuetical class. and also prepare 52,000 vials empty sterile vials, and 52,000 pieces of sterile stopper, and 52,000 pieces of caps.


2. mix 185 grams of HGH powder with 50,000ml of water and 2500 grams of mannitol and make them dissolved completely.


3. sterile filtering the solution above, using small 0.22 micrometer filter.


4. fill 1mg of solution above into each of the vials, then half stopper them.


5. lyophilizing them, using a lyophilizer.


7. stoppering them completely.


8. capping them.


All the vials and utensils which contact HGH must be washed at least 5 times by water for injection, then dried and sterilization.

3. There are class 10,000 and class 100 clean rooms in our factory



Two clean areas are of particular importance to sterile drug product quality: the critical area and the supporting clean areas associated with it.


A. Critical Area – Class 100 (ISO 5)


A critical area is one in which the sterilized drug product, containers, and closures are exposed to environmental conditions that must be designed to maintain product sterility (§ 211.42(c)(10)). Activities conducted in such areas include manipulations (e.g., aseptic connections, sterile ingredient additions) of sterile materials prior to and during filling and closing operations.


This area is critical because an exposed product is vulnerable to contamination and will not be subsequently sterilized in its immediate container. To maintain product sterility, it is essential that the environment in which aseptic operations (e.g., equipment setup, filling) are conducted be controlled and maintained at an appropriate quality. One aspect of environmental quality is the particle content of the air. Particles are significant because they can enter a product as an extraneous contaminant, and can also contaminate it biologically by acting as a vehicle for microorganisms (Ref. 2). Appropriately designed air handling systems minimize particle content of a critical area.


Air in the immediate proximity of exposed sterilized containers/closures and filling/closing operations would be of appropriate particle quality when it has a per-cubic-meter particle count of no more than 3520 in a size range of 0.5 µm and larger when counted at representative locations normally not more than 1 foot away from the work site, within the airflow, and during filling/closing operations. This level of air cleanliness is also known as Class 100 (ISO 5).


We recommend that measurements to confirm air cleanliness in critical areas be taken at sites where there is most potential risk to the exposed sterilized product, containers, and closures. The particle counting probe should be placed in an orientation demonstrated to obtain a meaningful sample. Regular monitoring should be performed during each production shift. We recommend conducting nonviable particle monitoring with a remote counting system. These systems are capable of collecting more comprehensive data and are generally less invasive than portable particle counters. See Section X.E. for additional guidance on particle monitoring.


Some operations can generate high levels of product (e.g., powder) particles that, by their nature, do not pose a risk of product contamination. It may not, in these cases, be feasible to measure air quality within the one-foot distance and still differentiate background levels of particles from air contaminants. In these instances, air can be sampled in a manner that, to the extent possible, characterizes the true level of extrinsic particle contamination to which the product is exposed. Initial qualification of the area under dynamic conditions without the actual filling function provides some baseline information on the non-product particle generation of the operation.


HEPA-filtered4 air should be supplied in critical areas at a velocity sufficient to sweep particles away from the filling/closing area and maintain unidirectional airflow during operations. The velocity parameters established for each processing line should be justified and appropriate to maintain unidirectional airflow and air quality under dynamic conditions within the critical area (Ref. 3).


Proper design and control prevents turbulence and stagnant air in the critical area. Once relevant parameters are established, it is crucial that airflow patterns be evaluated for turbulence or eddy currents that can act as a channel or reservoir for air contaminants (e.g., from an adjoining lower classified area). In situ air pattern analysis should be conducted at the critical area to demonstrate unidirectional airflow and sweeping action over and away from the product under dynamic conditions. The studies should be well documented with written conclusions, and include evaluation of the impact of aseptic manipulations (e.g., interventions) and equipment design. Videotape or other recording mechanisms have been found to be useful aides in assessing airflow initially as well as facilitating evaluation of subsequent equipment configuration changes. It is important to note that even successfully qualified systems can be compromised by poor operational, maintenance, or personnel practices.


Air monitoring samples of critical areas should normally yield no microbiological contaminants. We recommend affording appropriate investigative attention to contamination occurrences in this environment.


B. Supporting Clean Areas


Supporting clean areas can have various classifications and functions. Many support areas function as zones in which nonsterile components, formulated products, in-process materials, equipment, and container/closures are prepared, held, or transferred. These environments are soundly designed when they minimize the level of particle contaminants in the final product and control the microbiological content (bioburden) of articles and components that are subsequently sterilized. The nature of the activities conducted in a supporting clean area determines its classification. FDA recommends that the area immediately adjacent to the aseptic processing line meet, at a minimum, Class 10,000 (ISO 7) standards (see Table 1) under dynamic conditions. Manufacturers can also classify this area as Class 1,000 (ISO 6) or maintain the entire aseptic filling room at Class 100 (ISO 5). An area classified at a Class 100,000 (ISO 8) air cleanliness level is appropriate for less critical activities (e.g., equipment cleaning).

About quality management:

The quality control deparment is response of test of samples. And QA deparment is response of checking all of the staff to follow SOPs(standard of operation).



1. HGH samples should be tested according to following items


Items of Test Standard
Characters White lyophilized powder
Identification
A. IEF CORRESPONDS TO THE REFERENCE
B. HPLC/RP CORRESPONDS TO THE REFERENCE
C. PEPTIDE MAPPING CORRESPONDS TO THE REFERENCE
D. HPLC/SEC CORRESPONDS TO THE REFERENCE
RELATED PROTEINS (HPLC/RP) ≤ 13.0%
DIMER&RELATED SUBSTANCES
OF HIGHER MOLECULAR MASS
(HPLC/SEC)
≤ 6.0%
ISOFORM DISTRIBUTION CORRESPONDS TO THE REFERENCE
WATER ≤ 3.0%
BACTERIAL ENDOTOXINS < 5.0 IU/mg hGH
HOST-CELL-DRIVED PROTEINS ≤ 30 ng/mg hGH
HOST-CELL & VECTOR-DERIVED DNA ≤ 10 ng/dose hGH
TEST FOR STERILITY conformed
ASSAY (HPLC/SEC) 89.0% - 105.0 % the amount of Somatropin stated on the label
Purity (HPLC) ≥ 95%

2. Endotoxin Control


Endotoxin contamination of an injectable product can occur as a result of poor CGMP controls.
Certain patient populations (e.g., neonates), those receiving other injections concomitantly, or
those administered a parenteral in atypically large volumes or doses can be at greater risk for
pyrogenic reaction than anticipated by the established limits based on body weight of a normal
healthy adult (Ref. 6, 7). Such clinical concerns reinforce the importance of exercising
appropriate CGMP controls to prevent generation of endotoxins. Drug product components,
containers, closures, storage time limitations, and manufacturing equipment are among the areas
to address in establishing endotoxin control.


Adequate cleaning, drying, and storage of equipment will control bioburden and prevent
contribution of endotoxin load. Equipment should be designed to be easily assembled and
disassembled, cleaned, sanitized, and/or sterilized. If adequate procedures are not employed,
endotoxins can be contributed by both upstream and downstream processing equipment.


Sterilizing-grade filters and moist heat sterilization have not been shown to be effective in
removing endotoxin. Endotoxin on equipment surfaces can be inactivated by high-temperature
dry heat, or removed from equipment surfaces by cleaning procedures. Some clean-in-place
procedures employ initial rinses with appropriate high purity water and/or a cleaning agent (e.g.,
acid, base, surfactant), followed by final rinses with heated WFI. Equipment should be dried
following cleaning, unless the equipment proceeds immediately to the sterilization step.



3. Microbiological Media and Identification


Characterization of recovered microorganisms provides vital information for the environmental
monitoring program. Environmental isolates often correlate with the contaminants found in a
media fill or product sterility testing failure, and the overall environmental picture provides
valuable information for an investigation. Monitoring critical and immediately surrounding
clean areas as well as personnel should include routine identification of microorganisms to the
species (or, where appropriate, genus) level. In some cases, environmental trending data have
revealed migration of microorganisms into the aseptic processing room from either uncontrolled
or lesser controlled areas. Establishing an adequate program for differentiating microorganisms
in the lesser-controlled environments, such as Class 100,000 (ISO 8), can often be instrumental
in detecting such trends. At minimum, the program should require species (or, where
appropriate, genus) identification of microorganisms in these ancillary environments at frequent
intervals to establish a valid, current database of contaminants present in the facility during
processing (and to demonstrate that cleaning and sanitization procedures continue to be
effective).


Genotypic methods have been shown to be more accurate and precise than traditional
biochemical and phenotypic techniques. These methods are especially valuable for
investigations into failures (e.g., sterility test; media fill contamination). However, appropriate
biochemical and phenotypic methods can be used for the routine identification of isolates.
The goal of microbiological monitoring is to reproducibly detect microorganisms for purposes of
monitoring the state of environmental control. Consistent methods will yield a database that
allows for sound data comparisons and interpretations. The microbiological culture media used
in environmental monitoring should be validated as capable of detecting fungi (i.e., yeasts and
molds) as well as bacteria and incubated at appropriate conditions of time and temperature.


Total aerobic bacterial count can be obtained by incubating at 30 to 35 o C for 48 to 72 hours.
Total combined yeast and mold count can generally be obtained by incubating at 20 to 25 o C for 5
to 7 days.
Incoming lots of environmental monitoring media should be tested for their ability to reliably
recover microorganisms. Growth promotion testing should be performed on all lots of prepared
media. Where appropriate, inactivating agents should be used to prevent inhibition of growth by
cleanroom disinfectants or product residuals (e.g., antibiotics).


3. TIME LIMITATIONS


When appropriate, time limits must be established for each phase of aseptic processing.
Time limits should include, for example, the period between the start of bulk
product compounding and its sterilization, filtration processes, product exposure while on the
processing line, and storage of sterilized equipment, containers and closures. The time limits
established for the various production phases should be supported by data. Bioburden and
endotoxin load should be assessed when establishing time limits for stages such as the
formulation processing stage.


The total time for product filtration should be limited to an established maximum to prevent
microorganisms from penetrating the filter. Such a time limit should also prevent a significant
increase in upstream bioburden and endotoxin load. Because they can provide a substrate for
microbial attachment, maximum use times for those filters used upstream for solution
clarification or particle removal should also be established and justified.

Services:


The company has also set up a professional R&D department and gradually increased the R&D funding in the past three years for constant scientific and technological personnel introduction, scientific instruments and equipment procurement and further facilities improvement. Since the company was eastashed, we paid more attention to the new technologies research and development. Based on the existing technology platform, we have made breakthrough at the development of new indications, new applications, new specifications and new dosage forms, and formed a versatile products line including the products on sale and under R&D. While developing the new project, we applied for related patents and formed our own independent intellectual property rights.

Our Team:


Production Team:


1: OEM/ODM is  available.

2: The production department includes fermentation section, purification section, filling section and package section.

3. The manager of department and the section leaders have degrees of Bachelor or Master in Science. All of the staff were trained regularly according to current GMP regulations or standard operation procedure.

4. Each point of the production process is controlled.


Quality Control (QC) Team:


1: Each point of the production process was controlled by QC.
2: The QC department includes physics and chemistry section, instruments section and experimental animal section.
3. The manager of QC department and the section leaders have degrees of Bachelor or Master in Science. All of the staff were trained regularly according to current GMP regulations or standard operation procedure.

Quality Assurance (QA) Team


1: QA department is responsible for execution of all of SOPs (standard operation procedures) by the staff, inclluding all of the staff in the company.
2. The manager of QA department has degree of Bachelor or Master in Science. All of the staff were trained regularly according to current GMP regulations or standard operation procedure.


Marketing Team


1: Marketing department is responsible for selling the products from our company.
2. All of staff at marketing department have good ability in English or other languages.

3. They also have good knowledge about all of the products.

4. All of your inquiry or emails will be answered within 24 hours.


Shipment Service:


1: Your order will be shipped in parcel or carton within 24 hours after your payment. A few of your order may be shipped within 3 days after payment.

2: Shipment method is EMS, DHL, TNT, or FEDEX. Generally, most of your parcels will arrive within one week. A few of the parcels will arrive within two weeks because of the long distance.

3. They will send notices to you if your parcels have arrived and you have not gotten them.

4. We have a policy that if your parcels can not arrive in your country safely, we will re-ship it once, but not the third time.












Copyright © HongKong Health-keeping Bio-technology Company Ltd

service

home

products

company

contact